How does antigen binding trigger the BCR and B cell activation? We still don't know. But @sedegn and I review recent exciting progress here: https://t.co/uRHkWHirXz
How do B cells transform into cancers? We are hiring a postdoc to work on targeting oncogenic signalling by the B cell receptor in lymphoma. A @bloodcancer_uk funded position at @iit_ucl in our new labs in Hampstead, London, UK. Apply here: https://t.co/bOBEMmbFY2
I am happy to announce the final programme is out; it will be a very exciting meeting for everyone interested in B/T cell lymphoma and newest advances in biology and translational medicine! Only few places left; please sign up/ RT! https://t.co/QY37NLBFcg
We are looking for a post-doc with a background in immunology to work on the impact of RAS oncogenic signaling on the interaction of lung cancers with the immune system. Fully funded four year position at Francis Crick Institute in London. #Crick https://t.co/RFbqyRoLft
Massive congratulations to @Leo1401j for his Wellcome Career Development Award...a whole EIGHT years of funding to expand his fantastic research group @iit_ucl ๐คฉ๐๐พ๐ฅ๐พ
State of the art molecular immunology in an idyllic Tuscan landscape! Applications are open for the Lymphocyte Antigen Receptor Signalling Workshop at the Certosa di Pontignano 1-5 June 2024. https://t.co/tBsSPpbDaY
Transient plasma cell depletion with BCMAxCD3 plus sustained IL-4Rฮฑ blockade eliminates IgE production and durably reverses allergy @ScienceTM
https://t.co/njYhpja3Wq